Amanda Ayers, MD
Colon & Rectal Surgery · Bloomfield, CTNPI 1528268182
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Intuitive Surgical at 54.5% of the total. Reporting peaked in 2024 at $1,767 and has fallen 98.7% since, to $23 in 2025.
Across 62 payments — averaging $45.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Axonics, Inc.$245
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$228
- Takeda Pharmaceuticals U.S.A., Inc.$128
- Ironwood Pharmaceuticals, Inc$125
- Dentsply IH AB$57
- plus $508 from 19 others
Across 2 payments — averaging $5380.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$11K
What the payments were for
- Travel & lodging$1606%
- Food & beverage$1,18142%
- Education$1,50053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $1,549 |
| Axonics, Inc. | 7 | $245 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $128 |
| Ironwood Pharmaceuticals, Inc | 5 | $125 |
| Dentsply IH AB | 1 | $57 |
| Boston Scientific | 3 | $52 |
| Ferring Pharmaceuticals Inc. | 3 | $46 |
| Johnson & Johnson(2 entities) | 2 | $40 |
| Olympus America Inc. | 1 | $38 |
| Bayer | 1 | $35 |
| Medtronic | 1 | $30 |
| KCI USA, Inc. | 1 | $29 |
| Bristol Myers Squibb | 1 | $25 |
| THD America, Inc. | 2 | $25 |
| Novo Nordisk | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| Masimo Corporation | 1 | $17 |
| Novum Pharma, LLC | 1 | $17 |
| Gilead | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
How this compares
$2,840 in reported general payments places this provider in the 70th percentile of 48 colon & rectal surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 15 | $2,593 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 12 | $794 |
| Neomycin Sulfate | 11 | $63 |
| Metronidazole | 13 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ferring Pharmaceuticals Inc.Clenpiq | $46 | $2,59315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 48 colon & rectal surgery providers in Connecticut.
Other colon & rectal surgery in Bloomfield
- Rachel ScottBloomfield$5K
- Robert LewisBloomfield$4K
- Daniel MullinsBloomfield$3K
- Andrew RaissisBloomfield$1K
- Jonathan ChangBloomfield$1K
- David WaltersBloomfield$500
- Saumitra BanerjeeBloomfield$205
- Vanessa BarattaBloomfield$76
- John MonsonDanbury$182K
- George YavorekNew Haven$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.